Keytruda Pembrolizumab 100mg injection

Keytruda Pembrolizumab 100mg injection

Category: Tags: , , , , , , , , , , ,

$2,960.00

Before taking this medicine

To make sure Keytruda is safe for you, tell your doctor if you have:

a lung disease or a breathing disorder;
liver or kidney disease;
a thyroid disorder;
an autoimmune disorder such as lupus, Crohn’s disease, or ulcerative colitis; or
if you have ever had an organ transplant.

Do not use Keytruda if you are pregnant. It could harm the unborn baby. Tell your doctor right away if you become pregnant during treatment. Use effective birth control while you are using this medicine and for at least 4 months after your last dose.

It is not known whether pembrolizumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using Keytruda and for at least 4 months after your last dose.

Compare

Description

Keytruda Pembrolizumab 100mg injection Keytruda 100mg (pembrolizumab) is a cancer medicine that interferes with the growth and spread of cancer cells in the body.

Keytruda is used to treat:

advanced skin cancer (melanoma) that has spread to other parts of the body or cannot be surgically removed;
a certain type of non-small cell lung cancer, if your tumor has a specific genetic marker for which your doctor will test;
head and neck cancer that has spread to other parts of the body, or has come back after prior treatment;
classical Hodgkin lymphoma in adults and children;
a certain type of bladder and urinary tract cancer that has spread to other parts of the body or cannot be surgically removed; and
a type of cancer that laboratory testing proves to be a microsatellite instability-high or a mismatch repair deficiency solid tumor.

https://konozahealthbiotech.com

Keytruda is often given after other cancer medicine has been tried without success.

Keytruda was approved by the US Food and Drug Administration (FDA) on an “accelerated” basis to treat lung cancer or head and neck cancer. In clinical studies, tumors responded to this medicine. However, it has not been shown that pembrolizumab can improve symptoms or lengthen survival time.

Reviews

There are no reviews yet.

Be the first to review “Keytruda Pembrolizumab 100mg injection”

Your email address will not be published. Required fields are marked *